WHO ICTRP trial

A double-blind, randomized, uncontrolled study to evaluate inhibition of…

EUCTR2007-004544-73-DE · EU Clinical Trials Register · Not Recruiting

Key facts

Trial ID EUCTR2007-004544-73-DE
Public title A double-blind, randomized, uncontrolled study to evaluate inhibition of ovulation of two oral estradiol / drospirenone regimens in healthy young female volunteers over a period of 3 treatment cycles
Scientific title A double-blind, randomized, uncontrolled study to evaluate inhibition of ovulation of two oral estradiol / drospirenone regimens in healthy young female volunteers over a period of 3 treatment cycles
Primary sponsor Bayer Schering Pharma AG
Registry EU Clinical Trials Register
Recruitment status Not Recruiting
Study type Interventional clinical trial of medicinal product
Countries Germany
Conditions The trial will be performed in healthy female volunteers. The intended indication is female contraception.
Interventions Product Code: SH T04984E Pharmaceutical Form: Film-coated tablet INN or Proposed INN: Estradiol CAS Number: 50-28-2 Current Sponsor code: ZK 5018 Other descriptive name: Estradiol hemihydrate Concentration unit: mg milligram(s)…
Registration date Dec 11, 2007
Secondary IDs 311623
Registry page clinicaltrialsregister.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations